Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

Share Price is delayed by 15 minutes
Get Live Data
33.70    0.00 (0.00%)
Bid:
33.70
Ask:
34.40
Spread: 0.70 (2.077%)
Market Cap: £24.74m
CAR Live PriceLast checked at - London Stock Exchange

Intraday Carclo Share Chart

Trading Update

5 Sep 2024 07:00

RNS Number : 9408C
Carclo plc
05 September 2024
 

05 September 2024

 

 

Carclo plc

 

Trading Update

Carclo plc, the leading global provider of high-precision components, offering comprehensive services from mould design, automation and production to assembly and printing, serving the life sciences, aerospace, optics and tech sectors, provides the following trading update ahead of our AGM.

Financial Performance

Our strategic focus on improving our balance sheet, enhancing asset utilisation, prioritising margin over volume, and maximising our global footprint continues to yield positive results.

The Group's trading performance year to date is in line with management's expectations. The US manufacturing rationalisation and improvement programme is on track. By focussing on cash management and leveraging stronger trading, we have further improved our net debt to uEBITDA ratio. This progress highlights our unwavering commitment to strengthening our financial health across all operations.

Our expectations for the FY25 full year and FY26 remain unchanged with margin expansion anticipated to continue as the Group starts to see the full benefits of the operational optimisation process, continuing our journey toward our strategic goals of 10% return on sales and 25% return on capital employed.

CTP Design & Engineering

Our CTP Design & Engineering division maintains its focus on asset revitalisation projects, which are crucial for driving the next phase of operational improvements. This strategic emphasis underlines our commitment to sustainably enhancing overall company performance and meeting the evolving needs of our clients. These efforts continue to strengthen Carclo's leadership position in the sector, with a clear vision for sustained, medium-term growth.

CTP US Manufacturing Solutions

The restructuring of our US operations is progressing ahead of schedule, as highlighted during our full-year results presentation. We have successfully completed final production runs in Tucson and are now fully focused on our operational turnaround strategy at our centralised facility in Pennsylvania.

New leadership teams in our specialised production cells are beginning to drive important improvements in asset utilisation and operational performance, which are leading to the expected enhancement in margins. These proactive measures position us well to address short-term challenges while keeping our eyes on the medium to long-term strategic goals.

CTP EMEA Manufacturing Solutions

Our CTP EMEA Manufacturing Solutions division continues to build on its strong performance as we focus on the next phase of operational improvement through material and process optimisation. Following the new operational setup in EMEA, the region has emerged even stronger, with lasting enhancements in operational efficiency.

We have achieved an optimal balance of efficiency and flexibility by establishing long-run operations in the UK and medium-flexible runs at our facility in the Czech Republic, which enables us to effectively meet the growing demands of the EMEA market.

Speciality Division

We have now combined our Aerospace and Specialised Optics businesses into our Speciality Division, dedicated to providing customised solutions for niche markets. Both sectors utilise a strong market position built on specialised precision components, ongoing innovation, and exceptional customer support. The Aerospace sector, in particular, has continued its growth trajectory, showcasing the success of our strategic initiatives and commitment to precision leadership. Our expanding precision machining capabilities have enhanced our product offerings, further strengthening Carclo's respected position in the aerospace industry. These accomplishments reflect our steadfast commitment to quality and innovation across all specialty operations.

Further details will be provided in our interim results for the six months ending 30 September 2024, which will be released later this year.

 

LEI: 21380078MEM399JPI956

 

Enquiries:

Carclo plc +44 (0) 20 8685 0500

Frank Doorenbosch Chief Executive Officer

Eric Hutchinson Chief Financial Officer

 

 

Forward-looking statements

 

Certain statements made in this announcement are forward-looking statements. Such statements are based on current expectations and are subject to a number of risks and uncertainties that could cause outcomes to differ materially from those expected.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFFEAFISIIS
Date   Source Headline
5th Dec 20224:35 pmRNSPrice Monitoring Extension
30th Nov 20227:00 amRNSHalf-year Report
15th Nov 20227:05 amRNSNotice of Interim Results & Investor Presentation
15th Nov 20227:00 amRNSDirectorate Change
7th Nov 20227:00 amRNSBoard Changes
18th Oct 20227:00 amRNSTrading Update
13th Oct 20221:22 pmRNSHolding(s) in Company
6th Oct 20221:05 pmRNSAppointment of Chief Executive Officer
16th Sep 20223:16 pmRNSHolding(s) in Company
5th Sep 20227:00 amRNSTripartite Financing Agreement Secured
2nd Sep 202212:51 pmRNSHolding(s) in Company - Correction
2nd Sep 202210:37 amRNSHolding(s) in Company
1st Sep 20223:48 pmRNSHolding(s) in Company
1st Sep 20223:20 pmRNSResults of Annual General Meeting
15th Aug 20227:00 amRNSChange of Financial Adviser and Corporate Broker
4th Aug 20227:00 amRNSDirector/PDMR Shareholding
25th Jul 202211:10 amRNS2022 Annual Report and Notice of AGM
18th Jul 20224:41 pmRNSSecond Price Monitoring Extn
18th Jul 20224:35 pmRNSPrice Monitoring Extension
12th Jul 20223:56 pmRNSHolding(s) in Company
30th Jun 20227:20 amRNSNotice of Investor Presentation
30th Jun 20227:00 amRNSFinal Results
28th Jun 20227:00 amRNSNotice of Preliminary Results
7th Jun 20227:00 amRNSDirectorate Change
29th Apr 20227:00 amRNSFull Year Trading Update
9th Mar 20224:41 pmRNSSecond Price Monitoring Extn
9th Mar 20224:36 pmRNSPrice Monitoring Extension
21st Jan 20224:41 pmRNSSecond Price Monitoring Extn
21st Jan 20224:35 pmRNSPrice Monitoring Extension
18th Jan 20227:00 amRNSDirector/PDMR Shareholding
30th Dec 20214:42 pmRNSSecond Price Monitoring Extn
30th Dec 20214:36 pmRNSPrice Monitoring Extension
7th Dec 20214:41 pmRNSSecond Price Monitoring Extn
7th Dec 20214:36 pmRNSPrice Monitoring Extension
1st Dec 20212:57 pmRNSHolding(s) in Company
25th Nov 20217:00 amRNSDirector/PDMR Shareholding
24th Nov 20217:00 amRNSDirector/PDMR Shareholding
24th Nov 20217:00 amRNSDirector/PDMR Shareholding
19th Nov 20217:00 amRNSHalf Year Results
5th Nov 20217:00 amRNSNotice of Interim Results & Investor Presentation
2nd Sep 20213:08 pmRNSResults of Annual General Meeting
2nd Sep 20217:00 amRNSAGM Trading Update
6th Aug 20217:00 amRNSDirector/PDMR Shareholding
26th Jul 20212:47 pmRNS2021 Annual Report & Notice of AGM
1st Jul 20217:00 amRNSDirector/PDMR Shareholding
1st Jul 20217:00 amRNSDirector/PDMR Shareholding
30th Jun 20219:29 amRNSNotice of Investor Presentation
30th Jun 20217:00 amRNSPreliminary Results for the year ended 31 March 21
25th Jun 20217:00 amRNSNotice of Preliminary Results
7th May 20214:26 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.